Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BABY-UU Pilot Trial: Budesonide with Surfactant in Very Low Birth Weight Infants with Perinatal Ureaplasma Infection
ChiCTR2500114316Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of budesonide in bronchopulmonary dysplasia (BPD), respiratory distress syndrome (RDS) and Ureaplasma urealyticum infection (2 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Diagnosed with BPD or death at PMA 36 weeks. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)respiratory distress syndrome (RDS)Ureaplasma urealyticum infection
Beyond the preview
Go deeper on ChiCTR2500114316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114316.